Drug intelligence / Profile preview

Purasomes

Development stage
Unknown
Lead developer
Dermoaroma
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Topical, Intradermal
01

Overview

Purasomes is a line of secretome-based aesthetic products developed by Dermoaroma, an Italian research and development company. The formulations are powered by proprietary AMPLEX Plus technology, which utilizes secretomes and exosomes derived from organic bovine colostrum. Each treatment typically contains 20 billion exosomes and 20 functional growth factors. The product line includes several specialized formulations: Purasomes NC150+ (Nutri Complex) for skin regeneration and collagen production, Purasomes SGC100+ (Skin Glow Complex) for skin vitality and complexion enhancement, and Purasomes HSC50+ for hair restoration. These products are designed to reset cellular activity and enhance the body's natural healing response, stimulating fibroblast formation and improving skin structure, strength, and elasticity. They are intended for aesthetic skin rejuvenation and are typically administered through in-clinic procedures such as microneedling.

Brand names
PurasomesPurasomes NC150+Purasomes SGC100+Purasomes HSC50+
Other names
AMPLEX Plus
02

Targets

FGFR (FGFR family)

Beyond the preview

Go deeper on Purasomes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Purasomes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call